A purchasing analyst is comparing two quotes for the same research peptide. One sheet says “Purity: 98%+”. The other says “Purity (RP-HPLC, 220 nm, area %): not less than 98.0%; result 98.6%”. On a quick read they promise the same thing. They do not. The first is a claim. The second is a specification with a result attached to it, and only the second gives the analyst something that can be checked, compared and filed.
The three parts every specification needs
A usable specification line has three components, and it stops being meaningful the moment any one of them is missing:
- The attribute — the property being controlled, such as chromatographic purity, identity, water content or a named impurity.
- The method — how the attribute is measured, in enough detail that the number has a defined meaning (technique, detection wavelength, how the result is calculated).
- The acceptance criterion — the limit the result must meet, written as “not less than”, “not more than”, a range, or a qualitative requirement such as “conforms to reference”.
“98% pure” with no method is the classic incomplete line. Purity by HPLC area percent, purity by mass balance and net peptide content are different quantities, and the same material can give quite different numbers for each. The distinction is set out in purity versus net peptide content. Without the method, the attribute is undefined, and a limit on an undefined quantity constrains nothing.
A limit only works if the method can decide it
An acceptance criterion and the method used to test it have to be designed together. Two mismatches are common.
The limit is below what the method can quantify. If an HPLC method can reliably quantify impurities only down to 0.1%, a criterion of “any single impurity not more than 0.05%” cannot actually be assessed. A “pass” against it records a judgment the method was never able to make.
The limit is inside the method’s own uncertainty. If a purity result carries an uncertainty of around one percentage point, a result of 98.3% against a 98.0% limit is not a confident pass.
For a buyer, the practical point is simple: a tight number on a sheet is not the same as a tight control. The limit is only as sharp as the method behind it.
Where acceptance limits come from
Every limit has an origin, and the origin tells you what passing it means. Broadly there are four sources.
| Basis for the limit | What it rests on | What a pass tells you |
|---|---|---|
| Pharmacopoeial monograph | A published standard that fixes both the method and the limit. | The material meets a recognized public standard. Few research peptides have one. |
| Safety or toxicological reasoning | A quantity of a specific impurity with known significance, as for residual solvents or elemental impurities. | A particular risk has been bounded. |
| Process capability | What the manufacturing process consistently achieves, usually historical results plus a margin. | The material is typical of that process. It says nothing about fitness for a given experiment. |
| Market convention | A round number buyers have come to expect. | The supplier has met a customary threshold. |
For research peptides, convention and process capability account for most limits. That is not a problem in itself. A conventional limit that is met consistently, with a published result, still carries real information. It simply should not be read as though it had been derived from the needs of your assay. Whether 98% is enough for a given experiment is the purchaser’s scientific decision, not something a supplier’s limit settles.
What the specification does not mention
A specification constrains only the attributes it names. Everything else is uncontrolled by that document, however precise the named attributes look.
A practical example: a lyophilized peptide can satisfy a 98% HPLC purity limit while a substantial fraction of the vial’s weight is counter-ion and residual water. Neither is a chromatographic impurity, so neither affects the area-percent result, and if the specification does not list them, it places no limit on them. That is a gap in the specification, not necessarily a defect in the material. It matters most when a laboratory calculates concentrations from weighed mass; the background is in TFA versus acetate counter-ions.
Reading a specification well means noticing which obvious attributes are absent, not only checking the values that are present.
Release limits and end-of-period limits
More mature specification systems sometimes give the same attribute two limits: a tighter one that must be met when material is released and a wider one that applies until the end of its assigned retest or expiry period. Some degradation is expected over time, so material released right at the end-of-period limit would soon fall outside it. The gap between the two limits is set from stability data. Where one limit serves both purposes, it is either stricter than necessary at release or optimistic at the end of the period.
Three ways of reporting a result
Certificates and data sheets often use three phrasings as if they were interchangeable. They carry different amounts of information.
- “Not detected” means nothing appeared above the detection limit of the method used. It describes the method’s sensitivity as much as the sample.
- “Not more than X” as a result (rather than as a limit) says a measurement was made and fell below X, but hides the actual value.
- “Complies” or “conforms” says only that the criterion was judged to be met. It gives no number at all.
A numerical result is always more useful than a verdict. It lets a laboratory compare purchases and apply its own threshold. The broader reading of these documents is covered in the peptide certificate of analysis guide.
A five-question check for any specification
None of these questions needs a laboratory. They can be answered from the document in a few minutes and recorded in a supplier qualification file.
- Which attributes are controlled, and which obvious ones are missing?
- Is every criterion paired with a stated method?
- Could that method realistically decide the limit, given its quantitation limit and uncertainty?
- Is an actual value reported, or only a pass/fail statement?
- Was the limit derived from something, or is it a market convention?
Applied to Battle Born’s own documentation, the answers are straightforward. Each product is analyzed by independent reverse-phase HPLC and the purity result is published for that product, so the attribute, the method and the value are all visible. Because testing is done product by product rather than batch by batch, a vial is linked to its published test by crimp and cap color. Other attributes are not reported, and a laboratory that needs them should plan its own measurements.
Questions
Is a specification the same as a test result?
No. The specification is the requirement: attribute, method and limit. The result is the measured value. A useful document shows both, so the reader can see how close the result sits to the limit.
Why do different suppliers quote different purity limits for the same peptide?
Mostly because the limits are conventional or process-based rather than derived, and because the underlying methods differ. Two numbers measured by different methods are not directly comparable, as explained in why suppliers report different peptide purity.
Should my laboratory set its own acceptance criteria?
If an experiment depends on a particular attribute, yes. A purchaser’s internal criterion can be tighter than a supplier’s limit or cover attributes the supplier does not report, and it should name its own method.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.